- Home
- HBB vs CERT Comparison
HBB vs CERT Comparison
Compare HBB & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- CERT
- Stock Information
- Founded
- HBB 1904
- CERT 2008
- Country
- HBB United States
- CERT United States
- Employees
- HBB N/A
- CERT N/A
- Industry
- HBB Home Furnishings
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- HBB Consumer Discretionary
- CERT Technology
- Exchange
- HBB Nasdaq
- CERT Nasdaq
- Market Cap
- HBB 292.6M
- CERT 1.9B
- IPO Year
- HBB 2017
- CERT 2020
- Fundamental
- Price
- HBB $16.48
- CERT $10.71
- Analyst Decision
- HBB
- CERT Buy
- Analyst Count
- HBB 0
- CERT 7
- Target Price
- HBB N/A
- CERT $15.92
- AVG Volume (30 Days)
- HBB 51.2K
- CERT 1.4M
- Earning Date
- HBB 10-30-2024
- CERT 11-06-2024
- Dividend Yield
- HBB 2.70%
- CERT N/A
- EPS Growth
- HBB 107.04
- CERT N/A
- EPS
- HBB 1.88
- CERT N/A
- Revenue
- HBB $647,834,000.00
- CERT $372,797,000.00
- Revenue This Year
- HBB $4.60
- CERT $10.20
- Revenue Next Year
- HBB N/A
- CERT $10.43
- P/E Ratio
- HBB $8.71
- CERT N/A
- Revenue Growth
- HBB 5.30
- CERT 5.62
- 52 Week Low
- HBB $14.34
- CERT $9.41
- 52 Week High
- HBB $31.78
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- HBB 22.07
- CERT 45.72
- Support Level
- HBB $16.12
- CERT $10.31
- Resistance Level
- HBB $18.39
- CERT $11.77
- Average True Range (ATR)
- HBB 0.89
- CERT 0.58
- MACD
- HBB 0.01
- CERT -0.07
- Stochastic Oscillator
- HBB 0.02
- CERT 26.32
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.